tiprankstipranks
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market

VistaGen Therapeutics (VTGN) Technical Analysis

Compare
819 Followers

Technical Sentiment

Overall Consensus
Strong Sell
0Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
VistaGen Therapeutics’s (VTGN) Moving Averages Convergence Divergence (MACD) indicator is -0.06, suggesting VistaGen Therapeutics is a Buy.
VistaGen Therapeutics’s (VTGN) 20-Day exponential moving average is 2.67, while VistaGen Therapeutics’s (VTGN) share price is $2.34, making it a Sell.
VistaGen Therapeutics’s (VTGN) 50-Day exponential moving average is 2.74, while VistaGen Therapeutics’s (VTGN) share price is $2.34, making it a Sell.

VistaGen Therapeutics (VTGN) Pivot Points

Apr 02, 2025, 07:29 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.32
2.37
2.44
2.49
2.56
2.61
2.68
Fibonacci
2.37
2.42
2.45
2.49
2.54
2.57
2.61
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

VistaGen Therapeutics (VTGN) Moving Averages

Apr 02, 2025, 07:29 PM
Period
Simple
Exponential
MA5
2.54Sell
2.52Sell
MA10
2.67Sell
2.61Sell
MA20
2.70Sell
2.67Sell
MA50
2.77Sell
2.74Sell
MA100
2.77Sell
2.84Sell
MA200
3.04Sell
3.19Sell
VistaGen Therapeutics’s (VTGN) 10-Day exponential moving average is 2.61, while VistaGen Therapeutics’s (VTGN) share price is $2.34, making it a Sell.
VistaGen Therapeutics’s (VTGN) 100-Day exponential moving average is 2.84, while VistaGen Therapeutics’s (VTGN) share price is $2.34, making it a Sell.
VistaGen Therapeutics’s (VTGN) stock price is $2.34 and VistaGen Therapeutics’s (VTGN) 50-day simple moving average is 2.77, creating a Sell signal.
VistaGen Therapeutics’s (VTGN) stock price is $2.34 and VistaGen Therapeutics’s (VTGN) 100-day simple moving average is 2.77, creating a Sell signal.
VistaGen Therapeutics’s (VTGN) stock price is $2.34 and VistaGen Therapeutics’s (VTGN) 200-day simple moving average is 3.04, creating a Sell signal.

VistaGen Therapeutics (VTGN) Technical Indicators

Apr 02, 2025, 07:29 PM
Name
Value
Implied Action
RSI (14)
33.81
Neutral
STOCH (9,6)
7.45
Buy
STOCHRSI (14)
7.45
Buy
MACD (12,26)
-0.06
Buy
ADX (14)
12.51
Buy
Williams %R
-98.41
Buy
CCI (14)
-266.95
Buy
ATR (14)
0.17
-
Ultimate Oscillator
35.92
Neutral
ROC
-16.13
Sell
VistaGen Therapeutics’s (VTGN) Relative Strength Index (RSI) is 33.81, creating a Neutral signal.
VistaGen Therapeutics’s (VTGN) Trend Strength Indicator (ADX) is 12.51, creating a Buy signal.
VistaGen Therapeutics’s (VTGN) Commodity Channel Index (CCI) is -266.95, creating a Buy signal.
VistaGen Therapeutics’s (VTGN) Price Rate of Change (ROC) is -16.13, creating a Sell signal.

FAQ

Is VTGN a Buy, Hold, or Sell?
Based on VTGN’s technical indicators, VTGN is a Strong Sell.
    What is VTGN’s RSI (14)?
    VTGN’s RSI (14) is 33.81, which suggests VTGN is a Neutral.
      What is VTGN’s MACD?
      VTGN’s MACD is -0.06, which suggests VTGN is a Buy.
        What is VTGN’s 5-day moving average?
        VTGN’s 5-day moving average is 2.54, which suggests VTGN is a Sell.
          What is VTGN’s 20-day moving average?
          VTGN 20-day moving average is 2.70, which suggests VTGN is a Sell.
            What is VTGN’s 50-day moving average?
            VTGN’s 50-day moving average is 2.77, which suggests VTGN is a Sell.
              What is VTGN’s 200-day moving average?
              VTGN’s 200-day moving average is 3.04, which suggests VTGN is a Sell.
                What is VTGN’s Williams % R (14)?
                VTGN’s Williams % R (14) is -98.41, which suggests VTGN is a Buy.
                  What is VTGN’s CCI (14)?
                  VTGN’s CCI (14) is -266.95, which suggests VTGN is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis